Breaking News
December 12, 2017 - Novel approach could limit common complications of immunotherapy
December 12, 2017 - CAR T cell therapy shows long-lasting remissions in non-Hodgkin’s lymphoma patients
December 12, 2017 - Live-cell microscopy reveals internal forces that direct cell migration
December 12, 2017 - GSK Submits US Regulatory Application for Single-Dose Tafenoquine for Plasmodium vivax Malaria
December 12, 2017 - High Blood Urea Nitrogen Levels Tied to T2D Risk
December 12, 2017 - Blood Smear: MedlinePlus Lab Test Information
December 12, 2017 - Atopic eczema—one size does not fit all
December 12, 2017 - Biological Applications of AFM
December 12, 2017 - Genentech researchers uncover epigenetic regulator of pancreatic cancer cells
December 12, 2017 - Study provides new insights into mechanism of tumor survival in glioblastoma
December 12, 2017 - FDA Approves Admelog (insulin lispro) Short-Acting “Follow-On” Insulin Product to Treat Diabetes
December 12, 2017 - Chromosomes Fact Sheet – National Human Genome Research Institute (NHGRI)
December 12, 2017 - Discovery puts the brakes on HIV’s ability to infect
December 12, 2017 - Researchers uncover novel strategy to program immune system for fighting cancer
December 12, 2017 - Study finds under-age marriage for women as marker of multiple vulnerabilities
December 12, 2017 - Scientists discover specific mechanism of Zika virus-associated microcephaly
December 12, 2017 - Creating Your Family Health Tree
December 12, 2017 - Biological Pathways Fact Sheet – National Human Genome Research Institute (NHGRI)
December 12, 2017 - LSUHealthNO breakthrough may pave way for advances in obesity-related diseases
December 12, 2017 - Few people with HIV get prompt care after incarceration
December 11, 2017 - Air pollution exposure before or after conception linked to increased risk of birth defects in children
December 11, 2017 - Abu Dhabi focuses on reducing childhood obesity
December 11, 2017 - Employees with influenza have more lost work time
December 11, 2017 - type 2 diabetes – Genetics Home Reference
December 11, 2017 - Insufficient evidence to guide recommendations on vitamin D in pregnancy
December 11, 2017 - St. Jude gene therapy offers hope for infants with ‘bubble boy’ disease
December 11, 2017 - Soy foods, cruciferous vegetables may reduce breast cancer treatment’s side effects
December 11, 2017 - Nearly 3 in 10 elite footballers at top clubs have undetected lung and airway problems, study finds
December 11, 2017 - Why some workers can’t call it quits
December 11, 2017 - Healthier Diet, Less Salt: The Recipe to Beat High Blood Pressure: MedlinePlus Health News
December 11, 2017 - Research leads to call for lung health screening at top football clubs
December 11, 2017 - Drug improves disease-free, overall survival after hematopoietic stem cell transplants
December 11, 2017 - Researchers generate 3D cell cultures to investigate mechanisms of drug resistance in breast cancer
December 11, 2017 - New, more easily administered therapies offer benefits for bleeding and clotting disorders
December 11, 2017 - Opioids after surgery left her addicted. Is that a medical error?
December 11, 2017 - Scientists develop software that predicts leukemia-specific immune targets
December 11, 2017 - Does Your Pet Have a Weight Problem? Here’s How to Tell: MedlinePlus Health News
December 11, 2017 - Genetic variant prompts cells to store fat, fueling obesity
December 11, 2017 - Canola oil linked to worsening of Alzheimer’s
December 11, 2017 - New Breast Cancer Drug Ribociclib (Kisqali) May Benefit Younger Women, Too
December 11, 2017 - Healthy Living May Ease Some MS Symptoms: MedlinePlus Health News
December 11, 2017 - Researchers develop a molecular taxonomy for hair disorders
December 11, 2017 - Study shows safety, efficacy of cystic fibrosis drug in children between 1 to 2 years of age
December 11, 2017 - Two immunotherapy approaches for multiple myeloma show hope
December 11, 2017 - The Valley Hospital uses novel mobile app to enhance pre-hospital emergency care
December 11, 2017 - ‘I Entered Medical School Through a Hunger Strike’: What We Heard This Week
December 11, 2017 - Research team unlocks secrets of Ebola
December 11, 2017 - Generic versions of Viagra coming this week
December 11, 2017 - New genetic model identified for predicting outcomes in patients with primary myelofibrosis
December 11, 2017 - Research shows that e-cigarettes serve as gateway to traditional smoking
December 11, 2017 - A risk factor for drug-induced skin disease identified
December 11, 2017 - MIT researchers discover new way to make bacteria vulnerable to existing antibiotics
December 11, 2017 - Dengue vaccine issues in the Philippines
December 11, 2017 - Office Workers Don’t Like Being Chained to Their Desks: MedlinePlus Health News
December 11, 2017 - Study reveals how a very low calorie diet can reverse type 2 diabetes
December 11, 2017 - Study highlights potential for reducing greenhouse gas emissions in health care settings
December 11, 2017 - University of Adelaide receives $23.2 million for preterm birth research
December 11, 2017 - Tough Flu Season Ahead: Vaccine May Only Be 10% Effective
December 11, 2017 - Getting Self-Driving Cars on the Road Soon Might Save Lives: MedlinePlus Health News
December 11, 2017 - Enterovirus vaccine prevents virus-induced diabetes in a T1D experimental model
December 11, 2017 - Solar retinopathy or sun damage to the eyes – a case report
December 11, 2017 - Cancer risk with birth control pills emerges again in latest study
December 10, 2017 - Deer Hunters: Put Safety First: MedlinePlus Health News
December 10, 2017 - High blood pressure is redefined as 130, not 140: US guidelines (Update)
December 10, 2017 - Unusual neuroinflammation may underlie cognitive problems in cART-treated HIV patients
December 10, 2017 - Racial differences in parents’ reports of child’s autism symptoms may contribute to delayed diagnosis
December 10, 2017 - Taurine could boost effectiveness of existing multiple sclerosis therapies
December 10, 2017 - The man with a young woman’s heart
December 10, 2017 - Patient bedside remains important component of medical education for students
December 10, 2017 - Nutrition labeling has little impact on sodium consumption
December 10, 2017 - ‘Obesity paradox’ not present among people with new cases of cardiovascular disease
December 10, 2017 - SLU scientists provide promising approach in designing new drugs for DMD
December 10, 2017 - Can PD-1 Inhibitor Help Eradicate HIV?
December 10, 2017 - Checking Prices for Medical Procedures Online? Good Luck: MedlinePlus Health News
December 10, 2017 - Researchers find bacteria tied to esophageal cancer
December 10, 2017 - Boy’s Double Hand Transplant Changed His Brain
December 10, 2017 - Memo to Doctors: Spit Out the Bad News: MedlinePlus Health News
December 10, 2017 - Two years of extended anastrozole therapy proved as effective as five years in clinical trial
December 10, 2017 - Using digital devices before bed may contribute to sleep and nutrition problems in children
December 10, 2017 - Are You Sure That’s What the Doctor Said About Your Leukemia?: MedlinePlus Health News
AIDA project optimizes use of old antibiotics for better patient care

AIDA project optimizes use of old antibiotics for better patient care

image_pdfDownload PDFimage_print

A European consortium of researchers studied five off-patent community and hospital antibiotics with modern methods. They integrated the results of three randomized controlled clinical trials with extensive non-clinical studies. The results of this collaborative European project showed that real-life clinical studies have less favorable results compared to company-sponsored trials with selected and homogenous patient populations. Based on the project results, dosage regimens need to be updated and the use of old antibiotics revisited.

Recognizing the urgent need to optimize the use of old antibiotics, the European Union funded the multinational collaborative project AIDA (PRESERVING OLD ANTIBIOTICS FOR THE FUTURE) to fill the knowledge gaps for five old antibiotics. The researchers from 11 European countries challenged routine usage patterns and dosing regimens that were developed decades ago on a trial-and-error basis. They raised these questions: is the common use of the antibiotic colistin in combination with another antibiotic better than used alone in critically ill patients? Is a single-dose regimen of fosfomycin as effective as conventional therapy with nitrofurantoin in uncomplicated bladder infection? Is the combination of the old antibiotics rifampicin+minocycline as effective as linezolid for orally treated skin infections caused by MRSA?

The AIDA project accomplished three randomized controlled trials with each comparing two antibiotic regimens in infections caused by multidrug-resistant bacteria. The trials were designed to reflect real-life situations in clinical practice. Each of these three clinical studies was linked to a variety of laboratory and animal studies supporting and understanding clinical trial results. The collaboration of researchers from different disciplines and the successful completion of the AIDA project highlights the capacity of academic groups to “re-develop” old antibiotics and integrate complex clinical studies with high quality non-clinical research.

“AIDA will challenge some usage patterns and old believe about dosing regimens and clinical practice,” summarized Johan Mouton, coordinator of AIDA and Professor at Rotterdam University. Colistin is an antibiotic that was not used for almost half a century but revived as effective treatment for the most resistant bacteria. Johan Mouton: “We used colistin in critically ill patients based on little knowledge from the 1950s”. The AIDA project completed recruitment of patients of the clinical trial and contributes evidence to the common clinical practice of combining colistin with a carbapenem in cases of carbapenem-resistant bacteria. Mical Paul, who is Head of Infectious Diseases at Rambam Health Care Campus in Tel Aviv and led the extremely difficult randomized controlled trial in Intensive Care Unit patients concluded: “Finding evidence based on a large randomized controlled clinical trial that is supported by sophisticated microbiological and pharmacokinetic information provides the foundation for best patient care”. Recruiting a high number of critically ill patients infected by the most resistant Gram-negative bacteria is regarded as extremely challenging or even impossible. The AIDA project completed such a trial due to the high motivation and dedication of the medical teams in Israel, Greece and Italy.

The convenient single-dose oral treatment with fosfomyin in uncomplicated cystitis was also challenged in the AIDA project. The randomized controlled clinical trial was successfully completed and the results will be published soon. Anecdotal data had indicated a low response rate of a single dose of oral fosfomycin. The clinical trial results of the AIDA project clarified this question. Supported by pharmacokinetic studies and computer simulations these results may trigger a change in usage and more studies to define the best dosing regimen of oral fosfomyin.

Old antibiotics are off patent and no formal responsibility is defined for updating the knowledge of these valuable drugs. AIDA produced vital integrated non-clinical and clinical data to strengthen our evidence-based confidence for using these old drugs in daily clinical practice. “AIDA helped to shed light on the usage of vital old antibiotics that may support further activities of regulatory authorities,” adds Johan Mouton.

The AIDA project officially ends this year and will continue to publish all details that were generated during its lifetime.

Source:

http://www.aida-project.eu/

db83d669-5e6e-4e52-b1cf-53f237cd96f1|0|.0

Posted in: Healthcare News | Pharmaceutical News

Tags: Antibiotic, Bacteria, Bladder, Clinical Trial, Cystitis, Drugs, EU, Health Care, Hospital, Infectious Diseases, Intensive Care, Laboratory, Light, Minocycline, Rifampicin, Skin

Tagged with:

About author

Related Articles